Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway

Experimental Cell Research

Volumn 286, Issue 2, 2003, Pages 186-198

  McNeish, I A ^a   Bell, S ^a   McKay, T ^a   Tenev, T ^a,b   Marani, M ^a   Lemoine, N R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Adenovirus; Caspase; Cisplatin; Ovarian cancer; Smac DIABLO

Indexed keywords

ADENOVIRUS VECTOR; APOPTOSIS INDUCING FACTOR; CASPASE 12; CASPASE 3; CASPASE 8; CASPASE 9; CISPLATIN; CYTOCHROME C; ENZYME; ENZYME ACTIVATOR; ENZYME ACTIVATOR SMAC; ENZYME INHIBITOR; INHIBITOR OF APOPTOSIS PROTEIN; PACLITAXEL; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL LINE; CELL SURVIVAL; CONCENTRATION RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME RELEASE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; MITOCHONDRION; OVARY CARCINOMA; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; CUCUMBER MOSAIC VIRUS;

EID: 0038297558     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00073-9     Document Type: Article

References (42)

1. Reed J.C. Dysregulation of apoptosis in cancer. J. Clin. Oncol. 17:1999;2941-2953.
2. Wolf B.B., et al. Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity. J. Biol. Chem. 276:2001;34244-34251.
3. Shi Y.G. A structural view of mitochondria-mediated apoptosis. Nature. Struct. Biol. 8:2001;394-401.
4. Thornberry N., Lazebnik Y. Caspases enemies within . Science. 281:1998;1312-1316.
5. Nakagawa T., et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature. 403:2000;98-103.
6. Rao R.V., et al. Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J. Biol. Chem. 276:2001;33869-33874.
7. Silke J., Vaux D. Two kinds of BIR-containing protein - inhibitors of apoptosis, or required for mitosis. J. Cell Sci. 114:2001;1821-1827.
8. Harris M.H., Thompson C.B. The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability. Cell Death Differ. 7:2000;1182-1191.
9. Shimizu S., et al. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature. 399:1999;483-487.
10. Luo X., et al. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 94:1998;481-490.
11. Du C., et al. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell. 102:2000;33-42.
12. Verhagen A., et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell. 102:2000;43-53.
13. Liu Z.H., et al. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature. 408:2000;1004-1008.
14. Chai J., et al. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature. 406:2000;855-862.
15. Roberts D.L., et al. The inhibitor of apoptosis protein-binding domain of Smac is not essential for its proapoptotic activity. J. Cell Biol. 153:2001;221-228.
16. Chauhan D., et al. Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma (MM) cells. J. Biol. Chem. 276:2001;24453-24456.
17. Deng Y., et al. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev. 16:2002;33-45.
18. Guo Y., et al. Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J. Biol. Chem. 277:2002;13430-13437.
19. Sun X.-M., et al. Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of XIAP. J. Biol. Chem. 277:2002;11345-11351.
20. Hegde R., et al. Identification of Oml/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem. 277:2002;432-438.
21. Martins L.M., et al. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a Reaper-like motif. J. Biol. Chem. 277:2002;439-444.
22. Verhagen A.M., et al. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J. Biol. Chem. 277:2002;445-454.
23. Adrain C., et al. Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J. 20:2001;6627-6636.
24. Guo F., et al. Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis. Blood. 99:2002;3419-3426.
25. Fulda S., et al. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nature Med. 8:2002;808-815.
26. Tenev T., et al. Pro-caspase-3 overexpression sensitises ovarian cancer cells to proteasome inhibitors. Cell Death Differ. 8:2001;256-264.
27. McNeish I.A., et al. Herpes simplex virus thymidine kinase/ganciclovir-induced cell death is enhanced by co-expression of caspase-3 in ovarian carcinoma cells. Cancer Gene Ther. 8:2001;308-319.
28. Kovarik A., et al. Analysis of the tissue-specific promoter of the MUC1 gene. J. Biol. Chem. 268:1993;9917-9926.
29. He T.-C., et al. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA. 95:1998;2509-2514.
30. Mosmann T. Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays . J. Immunol. Methods. 65:1983;55-63.
31. Luetjens C.M., et al. Multiple kinetics of mitochondrial cytochrome c release in drug-induced apoptosis. Mol. Pharmacol. 60:2001;1008-1019.
32. Pandey P., et al. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J. 19:2000;4310-4322.
33. Asselin E., et al. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Cancer Res. 61:2001;1862-1868.
34. Ueno N.T., et al. E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway. Clin. Cancer Res. 6:2000;250-259.
35. Sasaki H., et al. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res. 60:2000;5659-5666.
36. Fadeel B., et al. Cleavage of Bcl-2 is an early event in chemotherapy-induced apoptosis of human myeloid leukemia cells. Leukemia. 13:1999;719-728.
37. Zhang X.D., et al. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by Smac/DIABLO release from mitochondria. Cancer Res. 61:2001;7339-7348.
38. Cuvillier O., Levade T. Sphingosine 1-phosphate antagonizes apoptosis of human leukemia cells by inhibiting release of cytochrome c and Smac/DIABLO from mitochondria. Blood. 98:2001;2828-2836.
39. Fujita E., et al. Caspase-9 processing by caspase-3 via a feedback amplification loop in vivo. Cell Death Differ. 8:2001;335-344.
40. Livne A., et al. Caspase activation by adenovirus E4orf4 protein is cell line specific and is mediated by the death receptor pathway. J. Virol. 75:2001;789-798.
41. Rao R.V., et al. Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J. Biol. Chem. 277:2002;21836-21842.
42. Yamabe K., et al. Cancer gene therapy using a pro-apoptotic gene, caspase-3. Gene Ther. 6:1999;1952-1959.